Holen Sie sich die Stockscreener-App
14.10
1.32%
0.11
Handel nachbörslich:
14.30
0.20
+1.42%
Schlusskurs vom Vortag:
$13.99
Offen:
$13.99
24-Stunden-Volumen:
21,791
Relative Volume:
0.79
Marktkapitalisierung:
$28.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.85M
KGV:
-45.48
EPS:
-0.31
Netto-Cashflow:
$-3.95M
1W Leistung:
+4.11%
1M Leistung:
+7.79%
6M Leistung:
-8.25%
1J Leistung:
-2.24%
1-Tages-Spanne:
$13.99
$14.28
1-Wochen-Bereich:
$13.49
$14.50
52-Wochen-Spanne:
$8.74
$22.90
Cadrenal Therapeutics Inc Stock (CVKD) Company Profile
Firmenname
Cadrenal Therapeutics Inc
Sektor
Branche
Telefon
904-300-0701
Adresse
822 A1A NORTH, PONTE VEDRA
Vergleichen Sie CVKD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVKD
Cadrenal Therapeutics Inc
|
14.10 | 28.64M | 0 | -4.85M | -3.95M | -0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-18 | Eingeleitet | Noble Capital Markets | Outperform |
Cadrenal Therapeutics Inc Aktie (CVKD) Neueste Nachrichten
Will Cadrenal Therapeutics Inc. stock go up soonJuly 2025 Patterns & Risk Controlled Swing Alerts - newser.com
What institutional flow reveals about Cadrenal Therapeutics Inc.2025 Market Outlook & Long Hold Capital Preservation Tips - newser.com
Is Cadrenal Therapeutics Inc a good long term investmentProtective Put Strategies & Unlock Long-Term Capital Growth Ideas - earlytimes.in
Applying chart zones and confluence areas to Cadrenal Therapeutics Inc.2025 Buyback Activity & Entry Point Confirmation Alerts - newser.com
Published on: 2025-10-13 02:03:23 - newser.com
How to escape a deep drawdown in Cadrenal Therapeutics Inc.July 2025 Retail & Free High Return Stock Watch Alerts - newser.com
Can Cadrenal Therapeutics Inc. recover in the next quarterMarket Performance Summary & Accurate Intraday Trading Signals - newser.com
What does recent volatility data suggest for Cadrenal Therapeutics Inc.Earnings Risk Report & Consistent Return Strategy Ideas - newser.com
Visual trend scoring systems applied to Cadrenal Therapeutics Inc.Long Setup & Weekly Setup with ROI Potential - newser.com
Cadrenal Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Backtesting results for Cadrenal Therapeutics Inc. trading strategiesBreakout Watch & Real-Time Chart Pattern Alerts - newser.com
Custom watchlist performance reports with Cadrenal Therapeutics Inc.2025 Price Momentum & Consistent Income Trade Ideas - newser.com
Cadrenal therapeutics CFO Szot sells $1496 in shares - Investing.com
Cadrenal Therapeutics Inc. stock daily chart insightsWeekly Volume Report & Community Shared Stock Ideas - newser.com
Can Cadrenal Therapeutics Inc. stock beat market expectations this quarterSwing Trade & Free Expert Verified Stock Movement Alerts - newser.com
Can Cadrenal Therapeutics Inc. stock sustain institutional interestMarket Trend Report & Risk Adjusted Buy/Sell Alerts - newser.com
Cadrenal Therapeutics Expands Pipeline With Portfolio Acquisition Worth Up To $15 Million - MSN
Insider Sell: Matthew Szot Sells Shares of Cadrenal Therapeutics Inc (CVKD) - GuruFocus
CVKD: Acquires Factor XIa Inhibitors - Smartkarma
CVKD: Acquires Factor XIa Inhibitors… - Yahoo Finance
Will a bounce in Cadrenal Therapeutics Inc. offer an exitWeekly Investment Recap & Consistent Return Investment Signals - newser.com
Cadrenal Therapeutics Inc Stock Analysis and ForecastVolume Analysis Techniques & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 - GlobeNewswire
Anticoagulation Therapy Biotech Cadrenal Therapeutics to Showcase Pipeline at Lytham Investor Conference - Stock Titan
Published on: 2025-09-30 10:26:28 - earlytimes.in
Multi factor analysis applied to Cadrenal Therapeutics Inc.2025 Support & Resistance & Daily Profit Maximizing Trade Tips - newser.com
What analysts say about Cadrenal Therapeutics Inc stockLow Beta Stocks & High Return Trading Ideas - earlytimes.in
Finanzdaten der Cadrenal Therapeutics Inc-Aktie (CVKD)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):